391 related articles for article (PubMed ID: 12090818)
1. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.
Spencer T; Biederman J; Coffey B; Geller D; Crawford M; Bearman SK; Tarazi R; Faraone SV
Arch Gen Psychiatry; 2002 Jul; 59(7):649-56. PubMed ID: 12090818
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents.
Otasowie J; Castells X; Ehimare UP; Smith CH
Cochrane Database Syst Rev; 2014 Sep; (9):CD006997. PubMed ID: 25238582
[TBL] [Abstract][Full Text] [Related]
3. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
Wilens TE; Biederman J; Prince J; Spencer TJ; Faraone SV; Warburton R; Schleifer D; Harding M; Linehan C; Geller D
Am J Psychiatry; 1996 Sep; 153(9):1147-53. PubMed ID: 8780417
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.
Scahill L; Chappell PB; Kim YS; Schultz RT; Katsovich L; Shepherd E; Arnsten AF; Cohen DJ; Leckman JF
Am J Psychiatry; 2001 Jul; 158(7):1067-74. PubMed ID: 11431228
[TBL] [Abstract][Full Text] [Related]
5. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.
Allen AJ; Kurlan RM; Gilbert DL; Coffey BJ; Linder SL; Lewis DW; Winner PK; Dunn DW; Dure LS; Sallee FR; Milton DR; Mintz MI; Ricardi RK; Erenberg G; Layton LL; Feldman PD; Kelsey DK; Spencer TJ
Neurology; 2005 Dec; 65(12):1941-9. PubMed ID: 16380617
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
Bloch MH; Panza KE; Landeros-Weisenberger A; Leckman JF
J Am Acad Child Adolesc Psychiatry; 2009 Sep; 48(9):884-893. PubMed ID: 19625978
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
Osland ST; Steeves TD; Pringsheim T
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder.
Gadow KD; Sverd J; Sprafkin J; Nolan EE; Ezor SN
Arch Gen Psychiatry; 1995 Jun; 52(6):444-55. PubMed ID: 7771914
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
Pringsheim T; Steeves T
Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
[TBL] [Abstract][Full Text] [Related]
10. The treatment of attention-deficit hyperactivity disorder in Tourette's syndrome: a double-blind placebo-controlled study with clonidine and desipramine.
Singer HS; Brown J; Quaskey S; Rosenberg LA; Mellits ED; Denckla MB
Pediatrics; 1995 Jan; 95(1):74-81. PubMed ID: 7770313
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
12. Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
Kelsey DK; Sumner CR; Casat CD; Coury DL; Quintana H; Saylor KE; Sutton VK; Gonzales J; Malcolm SK; Schuh KJ; Allen AJ
Pediatrics; 2004 Jul; 114(1):e1-8. PubMed ID: 15231966
[TBL] [Abstract][Full Text] [Related]
13. Donepezil use in children and adolescents with tics and attention-deficit/hyperactivity disorder: an 18-week, single-center, dose-escalating, prospective, open-label study.
Cubo E; Fernández Jaén A; Moreno C; Anaya B; González M; Kompoliti K
Clin Ther; 2008 Jan; 30(1):182-9. PubMed ID: 18343255
[TBL] [Abstract][Full Text] [Related]
14. Long-term methylphenidate therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder.
Gadow KD; Sverd J; Sprafkin J; Nolan EE; Grossman S
Arch Gen Psychiatry; 1999 Apr; 56(4):330-6. PubMed ID: 10197827
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive clonazepam treatment of tic symptoms in children with comorbid tic disorders and ADHD.
Steingard RJ; Goldberg M; Lee D; DeMaso DR
J Am Acad Child Adolesc Psychiatry; 1994; 33(3):394-9. PubMed ID: 8169185
[TBL] [Abstract][Full Text] [Related]
16. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
[TBL] [Abstract][Full Text] [Related]
17. Impact of tic disorders on ADHD outcome across the life cycle: findings from a large group of adults with and without ADHD.
Spencer TJ; Biederman J; Faraone S; Mick E; Coffey B; Geller D; Kagan J; Bearman SK; Wilens T
Am J Psychiatry; 2001 Apr; 158(4):611-7. PubMed ID: 11282697
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
19. A comparison of once-daily and divided doses of modafinil in children with attention-deficit/hyperactivity disorder: a randomized, double-blind, and placebo-controlled study.
Biederman J; Swanson JM; Wigal SB; Boellner SW; Earl CQ; Lopez FA;
J Clin Psychiatry; 2006 May; 67(5):727-35. PubMed ID: 16841622
[TBL] [Abstract][Full Text] [Related]
20. The 4-year course of tic disorders in boys with attention-deficit/hyperactivity disorder.
Spencer T; Biederman M; Coffey B; Geller D; Wilens T; Faraone S
Arch Gen Psychiatry; 1999 Sep; 56(9):842-7. PubMed ID: 12884890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
